Pediatr

Pediatr Infect Dis J 2002, 21:730–739.CrossRefPubMed 34. Feng P, Lampel KA, Karch H, Whittam TS: Genotypic and phenotypic changes in the emergence of Escherichia coli O157:H7. J Infect Dis 1998, 177:1750–1753.CrossRefPubMed 35. Lacher DW, Steinsland H, Blank TE, Donnenberg https://www.selleckchem.com/products/SB-203580.html MS, Whittam TS: Molecular evolution of typical enteropathogenic Escherichia coli : clonal analysis by multilocus sequence typing and virulence gene allelic profiling. J Bacteriol 2007, 189:342–350.CrossRefPubMed 36. Robins-Browne RM, Tokhi AM, Adams LM, Bennett-Wood V, Moisidis AV, Krejany EO, O’Gorman LE: Adherence characteristics

of attaching and effacing strains of Escherichia coli from rabbits. Infect Immun 1994, 62:1584–1592.PubMed 37. Karmali MA, Mascarenhas M, Shen S, Ziebell K, Johnson S, Reid-Smith R, Isaac-Renton J, Clark C, Rahn K, Kaper JB: Association of genomic O

island 122 of Escherichia coli EDL 933 with verocytotoxin-producing Escherichia coli seropathotypes that are linked to epidemic and/or serious disease. J Clin Microbiol 2003, 41:4930–4940.CrossRefPubMed 38. Afset JE, Bruant G, Brousseau R, Harel J, Anderssen E, Bevanger L, Bergh K: Identification of virulence genes linked with diarrhea due to atypical enteropathogenic Escherichia coli by DNA microarray analysis and PCR. J Clin Microbiol 2006, 44:3703–3711.CrossRefPubMed 39. Khan NA, Kim Y, Shin S, Kim KS: FimH-mediated Escherichia coli K1 invasion of human brain microvascular endothelial cells. Cell Microbiol 2007, Topoisomerase inhibitor 9:169–178.CrossRefPubMed 40. Mulvey MA: Adhesion and entry of uropathogenic Escherichia coli. Cell Microbiol 2002, 4:257–271.CrossRefPubMed 41. Moreira CG, Carneiro SM, Nataro JP, Trabulsi LR, Elias WP: Role of type I fimbriae in the aggregative adhesion pattern of enteroaggregative Escherichia coli. FEMS Microbiol Lett 2003, 226:79–85.CrossRefPubMed 42. Moreira CG, Palmer K, Whiteley M, Sircili MP, Trabulsi LR, Castro AF, Sperandio V: Bundle-forming pili and EspA are involved in biofilm formation by enteropathogenic Escherichia coli. J Bacteriol

2006, 188:3952–3961.CrossRefPubMed 43. Boudeau J, Barnich N, Darfeuille-Michaud A: Type 1 pili-mediated adherence of Escherichia coli strain LF82 EGFR antibody inhibitor isolated from Crohn’s disease is involved in bacterial invasion of intestinal epithelial cells. Mol Microbiol 2001, 39:1272–1284.CrossRefPubMed 44. Francis CL, Jerse AE, Kaper JB, Falkow S: Characterization on interactions of enteropathogenic Escherichia coli O127:H6 with mammalian cells in vitro. J Infect Dis 1991, 164:693–703.PubMed 45. Orskov F: On the occurrence of E. coli belonging to O-group 26 in cases of infantile diarrhoea and white scours. Acta Pathologica et Microbiologica Scandinavica 1951, 29:373–378.CrossRefPubMed 46. Taylor J, Maltby MP, Payne JM: Factors influencing the response of ligated Cl-amidine rabbit-gut segments to injected Escherichia coli.

Comments are closed.